Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/1999
04/29/1999WO1998007715A9 Novel benzofuran-4-carboxamides
04/29/1999CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers
04/29/1999CA2307288A1 (3r,4r)-.delta.-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
04/29/1999CA2306870A1 Bicyclic kinase inhibitors
04/29/1999CA2306204A1 J-chain and analogues as epithelial cell targeting conjugates
04/29/1999CA2305798A1 .alpha.-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
04/28/1999EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5
04/28/1999EP0911399A2 A kringle-related clone, HTHBZ47
04/28/1999EP0911342A1 Novel protein and process for producing the same
04/28/1999EP0911319A1 Malonic acid based matrix metalloproteinase inhibitors
04/28/1999EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha
04/28/1999EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis
04/28/1999EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases
04/28/1999EP0910397A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
04/28/1999EP0910395A1 Pharmaceutical composition which is stable during storage and contains a thymus extract
04/28/1999EP0910384A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
04/28/1999EP0910368A1 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
04/28/1999EP0910364A1 Buffered compositions containing a local anaesthetic and used as an anti-inflammatory
04/28/1999EP0910361A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
04/28/1999EP0910358A1 Phenyl derivatives useful as blockers of chloride channels
04/28/1999EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
04/28/1999EP0779888B1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them
04/28/1999EP0723555A4 Chimeric proteins which block complement activation
04/28/1999EP0679092B1 Cytokine restraining agents
04/28/1999EP0618907B1 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents
04/28/1999CN1215407A Human antibodies that bind huma TNF 'alpha'
04/28/1999CN1215397A Acylated N-hydroxy methyl thalidomide prodrugs with immunomodulator action
04/28/1999CN1215396A Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
04/28/1999CN1215391A 6-phenylpyridyl-2-amine derivatives
04/28/1999CN1215340A Composition comprising interleukin-1 inhibitor and controlled release polymer
04/28/1999CN1214922A Traditional Chinese medicine composition for external use of curing rheumatic arthritis
04/28/1999CN1043141C Heterocyclic amines compound, its preparation process, medicinal composition containing same and medical use thereof
04/27/1999US5898033 Antiinflammatory non-immunogenic conjugate comprising polyamino acid backbone having multiplicity of molecules of non-steroidal antiinflammatory agent linked thereto, which is preferentially internalized by antigen-processing cells
04/24/1999CA2248170A1 A clone hwhhj20
04/22/1999WO1999019486A1 Cell division regulators
04/22/1999WO1999019477A1 Cadherin derived growth factor and the application thereof
04/22/1999WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
04/22/1999WO1999019351A1 Novel npy family member
04/22/1999WO1999019339A1 53 human secreted proteins
04/22/1999WO1999018987A1 Ligand binding site of rage and uses thereof
04/22/1999WO1999018960A1 Novel combination
04/22/1999WO1999018938A1 Delayed total release gastrointestinal drug delivery system
04/22/1999WO1999018935A1 Preparation of a directly mouldable tabletting auxiliary
04/22/1999WO1999018801A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
04/22/1999WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof
04/22/1999WO1999006361A3 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
04/22/1999WO1999001136A9 Novel substituted imidazole compounds
04/22/1999DE19845339A1 Directly compressible tabletting aid
04/22/1999CA2308009A1 Novel npy family member
04/22/1999CA2307328A1 Cell division regulators
04/22/1999CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
04/22/1999CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
04/22/1999CA2305690A1 53 human secreted proteins
04/22/1999CA2305141A1 Novel combination
04/21/1999EP0909763A2 Colchicine derivatives and the therapeutical use thereof
04/21/1999EP0909556A1 Rosaceae extract as bradykinin antagonist
04/21/1999EP0909173A1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders
04/21/1999EP0793641B1 Metalloproteinase inhibitors
04/21/1999EP0743938B1 Substituted spiro compounds for the treatment of inflammation
04/21/1999CN1214677A Diphenyl stilbenes as prodrugs to cox-2 inhibitors
04/21/1999CN1214629A Solid instant-release forms of administration and process for producing the same
04/15/1999WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/15/1999WO1999018070A1 Novel vitamin d analogues
04/15/1999WO1999017806A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
04/15/1999WO1999017796A2 Modulation of lerk-2-mediated cell adhesion
04/15/1999WO1999017792A1 Methods and compositions for treating rheumatoid arthritis
04/15/1999WO1999017787A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
04/15/1999WO1999017776A1 Novel cycloalkenyl substituted compounds
04/15/1999WO1999017775A1 QUINOLINE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
04/15/1999WO1999017773A1 Compounds and methods
04/15/1999WO1999017748A1 Taste masked pharmaceutical compositions
04/15/1999WO1999017744A1 Immediate release drug delivery forms
04/15/1999WO1999017743A1 Dosage forms having improved release properties
04/15/1999WO1999017709A2 Methods and compositions for treating rheumatoid arthritis
04/15/1999WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
04/15/1999WO1999002666A3 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
04/15/1999DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals
04/15/1999CA2308126A1 Modulation of lerk-2-mediated cell adhesion
04/15/1999CA2306273A1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
04/15/1999CA2306245A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy
04/15/1999CA2306077A1 Novel cycloalkenyl substituted compounds
04/15/1999CA2305805A1 Compounds and methods
04/15/1999CA2305688A1 Methods and compositions for treating rheumatoid arthritis
04/15/1999CA2304152A1 Novel vitamin d analogues
04/15/1999CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/15/1999CA2273274A1 Dosage forms having improved release properties
04/14/1999EP0908180A2 Use of phenyl oxazole or phenyl thiazole derivatives for treating pain
04/14/1999EP0907742A2 Cyclic nucleotide phosphodiesterase
04/14/1999EP0907732A2 Polynucleotides encoding secreted proteins
04/14/1999EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS
04/14/1999EP0907658A1 Neuropeptide y agonists
04/14/1999EP0907652A1 Immunosuppressive compounds and methods
04/14/1999EP0907646A1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
04/14/1999EP0907632A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
04/14/1999EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
04/14/1999EP0767777B1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations
04/14/1999EP0669938B1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION
04/14/1999EP0595924B1 Platelet activating factor antagonists
04/14/1999CN1214050A Human tumor necrosis factor delta and epsilon
04/14/1999CN1214048A Benzopyran derivatives having leukotriene-antagonistic action